Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery
Acute hyperglycemia alters von Willebrand factor but not the fibrinolytic system in elderly subjects with normal or impaired glucose tolerance
Factor V inhibitors
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men
Analysis of some clinical and laboratory aspects of adolescent patients with thrombosis
Effects of histidine-proline-rich glycoprotein on plasminogen activation in solution and on surfaces
Aging and oral anticoagulant therapy using acenocoumarol
Foodstate vitamin C complex may beneficially affect haemostasis and fibrin network structure in hyperlipidaemic patients
Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors
Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran
Venous thrombosis after knee arthroscopy in a factor V-deficient patient treated with virus-inactivated fresh frozen plasma
Recombinant activated factor VII (NovoSeven®) stops severe intra-abdominal bleeding after liver needle biopsy without surgery
Index to authors
Index to subjects
A note of thanks to referees Blood Coagulation and Fibrinolysis 2004, Volume 15